OptiNose

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OptiNose and buy or sell other stocks, ETFs, and their options commission-free!

About OPTN

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. 

CEO
Evan Loh, MD
CEOEvan Loh, MD
Employees
128
Employees128
Headquarters
Yardley, Pennsylvania
HeadquartersYardley, Pennsylvania
Founded
2000
Founded2000
Employees
128
Employees128

OPTN Key Statistics

Market cap
97.22M
Market cap97.22M
Price-Earnings ratio
-3.22
Price-Earnings ratio-3.22
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$20.03
52 Week high$20.03
52 Week low
$4.82
52 Week low$4.82

Stock Snapshot

The current OptiNose(OPTN) stock price is $9.60, with a market capitalization of 97.22M. The stock trades at a price-to-earnings (P/E) ratio of -3.22.

OptiNose(OPTN) stock opened on 2026-07-19 at —. The price climbed to — and dipped to —.

The OptiNose(OPTN)'s current trading volume is 0.

During the past year, OptiNose(OPTN) stock moved between $4.82 at its lowest and $20.03 at its peak.

During the past year, OptiNose(OPTN) stock moved between $4.82 at its lowest and $20.03 at its peak.

People also own

Based on the portfolios of people who own OPTN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.